Overweight Treatment Market

Market Study on Overweight Treatment: Supplements Account for Nearly 90% Market Share

Overweight Treatment Market Segmented By Drug Treatment, Supplements, Medical Devices / Implants Treatment

  • May-2022
  • PMRREP33086
  • 245 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption Analysis

    4.2. Obesity Rate by Country

    4.3. Obesity Drugs Pipeline Analysis

    4.4. Obesity Drug Withdrawal Analysis

    4.5. Obesity Drug / Device Withdrawal, Termination from Clinical Trials

    4.6. Regulatory Scenario

    4.7. Key Promotional Strategies by Manufacturers

    4.8. Porter’s Analysis

    4.9. PESTEL Analysis

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 Economic analysis

    5.4. COVID-19 and Impact Analysis

        5.4.1. Revenue by Treatment

        5.4.2. Revenue by Distribution Channel

        5.4.3. Revenue by Country

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Growth Outlook

        6.1.2. Per-Capita Healthcare Expenditure

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. COVID-19 Pandemic

        6.2.2. Increasing Prevalence of Obesity

        6.2.3. Rise in R&D Investments

        6.2.4. Top Overweight Treatment   Companies and Their Historical Growth

        6.2.5. Rise in Number of Clinical Studies

        6.2.6. Increasing Investment in Obesity Research

        6.2.7. GDP Growth

        6.2.8. Adoption Rate of Overweight Treatment Products

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global Overweight Treatment Market Demand (in Value or Size in US$ MN) Analysis 2017–2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ MN) Analysis, 2017–2021

    7.2. Current and Future Market Value (US$ MN) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032, by Treatment

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis by Treatment, 2017 - 2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Treatment, 2022 - 2032

        8.3.1. Drug Treatment

            8.3.1.1. Bupropion and Naltrexone

            8.3.1.2. Orlistat

            8.3.1.3. Phentermine and Topiramate

            8.3.1.4. Liraglutide

            8.3.1.5. Others

        8.3.2. Supplements

        8.3.3. Medical Devices / Implants

            8.3.3.1. Gastric Balloons

            8.3.3.2. Gastric Bands

            8.3.3.3. Stapling Devices

    8.4. Market Attractiveness Analysis by Treatment

9. Global Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032, by Distribution Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2017 - 2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2022- 2032

        9.3.1. Institutional Sales

            9.3.1.1. Hospitals

            9.3.1.2. Specialty Clinics

            9.3.1.3. Ambulatory Surgical Centers

        9.3.2. Retail Sales

            9.3.2.1. Retail Pharmacy

            9.3.2.2. Drug Stores

            9.3.2.3. Supermarkets/ Hypermarkets

            9.3.2.4. Health & Beauty Stores

        9.3.3. Online Sales

    9.4. Market Attractiveness Analysis by Distribution Channel

10. Global Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032, by Region

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis by Region, 2017 - 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2022- 2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 - 2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Treatment

        11.3.3. By Distribution Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Treatment

        11.4.3. By Distribution Channel

    11.5. Market Trends

    11.6. Key Market Participants - Intensity Mapping

    11.7. Drivers and Restraints - Impact Analysis

    11.8. Country Level Analysis & Forecast

        11.8.1. U.S. Overweight Treatment Market Analysis

            11.8.1.1. Introduction

            11.8.1.2. Market Analysis and Forecast by Market Taxonomy

                11.8.1.2.1. By Treatment

                11.8.1.2.2. By Distribution Channel

        11.8.2. Canada Overweight Treatment Market Analysis

            11.8.2.1. Introduction

            11.8.2.2. Market Analysis and Forecast by Market Taxonomy

                11.8.2.2.1. By Treatment

                11.8.2.2.2. By Distribution Channel

12. Latin America Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 - 2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032

        12.3.1. By Country

            12.3.1.1. Mexico

            12.3.1.2. Brazil

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

                12.3.1.4.1. By Treatment

                12.3.1.4.2. By Distribution Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Treatment

        12.4.3. By Distribution Channel

    12.5. Market Trends

    12.6. Key Market Participants - Intensity Mapping

    12.7. Drivers and Restraints - Impact Analysis

    12.8. Country Level Analysis & Forecast

        12.8.1. Mexico Overweight Treatment Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast by Market Taxonomy

                12.8.1.2.1. By Treatment

                12.8.1.2.2. By Distribution Channel

        12.8.2. Brazil Overweight Treatment Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast by Market Taxonomy

                12.8.2.2.1. By Treatment

                12.8.2.2.2. By Distribution Channel

        12.8.3. Argentina Overweight Treatment Market Analysis

            12.8.3.1. Introduction

            12.8.3.2. Market Analysis and Forecast by Market Taxonomy

                12.8.3.2.1. By Treatment

                12.8.3.2.2. By Distribution Channel

13. Europe Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 - 2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Nordic Countries & Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Treatment

        13.3.3. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Treatment

        13.4.3. By Distribution Channel

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. Germany Overweight Treatment Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Treatment

                13.8.1.2.2. By Distribution Channel

        13.8.2. Italy Overweight Treatment Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Treatment

                13.8.2.2.2. By Distribution Channel

        13.8.3. France Overweight Treatment Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast by Market Taxonomy

                13.8.3.2.1. By Treatment

                13.8.3.2.2. By Distribution Channel

        13.8.4. U.K. Overweight Treatment Market Analysis

            13.8.4.1. Introduction

            13.8.4.2. Market Analysis and Forecast by Market Taxonomy

                13.8.4.2.1. By Treatment

                13.8.4.2.2. By Distribution Channel

        13.8.5. Spain Overweight Treatment Market Analysis

            13.8.5.1. Introduction

            13.8.5.2. Market Analysis and Forecast by Market Taxonomy

                13.8.5.2.1. By Treatment

                13.8.5.2.2. By Distribution Channel

        13.8.6. BENELUX Overweight Treatment Market Analysis

            13.8.6.1. Introduction

            13.8.6.2. Market Analysis and Forecast by Market Taxonomy

                13.8.6.2.1. By Treatment

                13.8.6.2.2. By Distribution Channel

        13.8.7. Nordic Countries & Russia Overweight Treatment Market Analysis

            13.8.7.1. Introduction

            13.8.7.2. Market Analysis and Forecast by Market Taxonomy

                13.8.7.2.1. By Treatment

                13.8.7.2.2. By Distribution Channel

14. East Asia Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 - 2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

                14.3.1.3.1. By Treatment

                14.3.1.3.2. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Treatment

        14.4.3. By Distribution Channel

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. China Overweight Treatment Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Treatment

                14.8.1.2.2. By Distribution Channel

        14.8.2. Japan Overweight Treatment Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Treatment

                14.8.2.2.2. By Distribution Channel

        14.8.3. South Korea Overweight Treatment Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Treatment

                14.8.3.2.2. By Distribution Channel

15. South Asia Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 - 2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Indonesia

            15.3.1.3. Malaysia

            15.3.1.4. Philippines

            15.3.1.5. Thailand

            15.3.1.6. Vietnam

            15.3.1.7. Rest of South Asia

        15.3.2. By Treatment

        15.3.3. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Treatment

        15.4.3. By Distribution Channel

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. India Overweight Treatment Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Treatment

                15.8.1.2.2. By Distribution Channel

        15.8.2. Indonesia Overweight Treatment Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Treatment

                15.8.2.2.2. By Distribution Channel

        15.8.3. Malaysia Overweight Treatment Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Treatment

                15.8.3.2.2. By Distribution Channel

        15.8.4. Philippines Overweight Treatment Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Treatment

                15.8.4.2.2. By Distribution Channel

        15.8.5. Thailand Overweight Treatment Market Analysis

            15.8.5.1. Introduction

            15.8.5.2. Market Analysis and Forecast by Market Taxonomy

                15.8.5.2.1. By Treatment

                15.8.5.2.2. By Distribution Channel

        15.8.6. Vietnam Overweight Treatment Market Analysis

            15.8.6.1. Introduction

            15.8.6.2. Market Analysis and Forecast by Market Taxonomy

                15.8.6.2.1. By Treatment

                15.8.6.2.2. By Distribution Channel

16. Oceania Overweight Treatment Market 2017-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 - 2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Treatment

        16.3.3. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Treatment

        16.4.3. By Distribution Channel

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Australia Overweight Treatment Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Treatment

                16.8.1.2.2. By Distribution Channel

        16.8.2. New Zealand Overweight Treatment Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Treatment

                16.8.2.2.2. By Distribution Channel

17. Middle East and Africa (MEA) Overweight Treatment Market Analysis 2017–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 - 2021

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. Israel

            17.3.1.3. Turkey

            17.3.1.4. South Africa & North Africa

            17.3.1.5. Rest of Middle East and Africa

        17.3.2. By Treatment

        17.3.3. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Treatment

        17.4.3. By Distribution Channel

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. GCC Countries Overweight Treatment Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Treatment

                17.8.1.2.2. By Distribution Channel

        17.8.2. Israel Overweight Treatment Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Treatment

                17.8.2.2.2. By Distribution Channel

        17.8.3. Turkey Overweight Treatment Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Treatment

                17.8.3.2.2. By Distribution Channel

        17.8.4. South Africa & North Africa Overweight Treatment Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Treatment

                17.8.4.2.2. By Distribution Channel

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Share Analysis of Top Players

    18.3. Market Presence Analysis

        18.3.1. Regional footprint of Players

        18.3.2. Channel Foot Print by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Novo Nordisk A/S

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.1.4. Sales Footprint

            19.3.1.5. Strategy Overview

            19.3.1.6. SWOT Analysis

        19.3.2. VIVUS LLC

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.2.4. Sales Footprint

            19.3.2.5. Strategy Overview

            19.3.2.6. SWOT Analysis

        19.3.3. AstraZeneca

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.3.4. Sales Footprint

            19.3.3.5. Strategy Overview

            19.3.3.6. SWOT Analysis

        19.3.4. Currax Pharmaceuticals LLC.

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.4.4. Sales Footprint

            19.3.4.5. Strategy Overview

            19.3.4.6. SWOT Analysis

        19.3.5. Spansules Pharmatech Pvt Ltd

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.5.4. Sales Footprint

            19.3.5.5. Strategy Overview

            19.3.5.6. SWOT Analysis

        19.3.6. Atkins Nutritional Inc.

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.6.4. Sales Footprint

            19.3.6.5. Strategy Overview

            19.3.6.6. SWOT Analysis

        19.3.7. Apollo Endosurgery, Inc.

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.7.4. Sales Footprint

            19.3.7.5. Strategy Overview

            19.3.7.6. SWOT Analysis

        19.3.8. Herbalife Nutrition Ltd.

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.8.4. Sales Footprint

            19.3.8.5. Strategy Overview

            19.3.8.6. SWOT Analysis

        19.3.9. SMP Nutra

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.9.4. Sales Footprint

            19.3.9.5. Strategy Overview

            19.3.9.6. SWOT Analysis

        19.3.10. Allurion Technologies

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.10.4. Sales Footprint

            19.3.10.5. Strategy Overview

            19.3.10.6. SWOT Analysis

        19.3.11. ReShape Lifesciences, Inc.

            19.3.11.1. Overview

            19.3.11.2. Product Portfolio

            19.3.11.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.11.4. Sales Footprint

            19.3.11.5. Strategy Overview

            19.3.11.6. SWOT Analysis

        19.3.12. Bariatric Solutions GmbH

            19.3.12.1. Overview

            19.3.12.2. Product Portfolio

            19.3.12.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.12.4. Sales Footprint

            19.3.12.5. Strategy Overview

            19.3.12.6. SWOT Analysis

        19.3.13. Silimed

            19.3.13.1. Overview

            19.3.13.2. Product Portfolio

            19.3.13.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.13.4. Sales Footprint

            19.3.13.5. Strategy Overview

            19.3.13.6. SWOT Analysis

        19.3.14. ENDALIS

            19.3.14.1. Overview

            19.3.14.2. Product Portfolio

            19.3.14.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.14.4. Sales Footprint

            19.3.14.5. Strategy Overview

            19.3.14.6. SWOT Analysis

        19.3.15. Districlass Medical

            19.3.15.1. Overview

            19.3.15.2. Product Portfolio

            19.3.15.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.15.4. Sales Footprint

            19.3.15.5. Strategy Overview

            19.3.15.6. SWOT Analysis

        19.3.16. Medtronic

            19.3.16.1. Overview

            19.3.16.2. Product Portfolio

            19.3.16.3. Key Financials by Market Segments (Product/Channel/Region)

            19.3.16.4. Sales Footprint

            19.3.16.5. Strategy Overview

            19.3.16.6. SWOT Analysis

20. Assumptions and Acronyms Used

21. Research Methodology

Find Out More about the Report Coverage

List of Tables

Table 01: Global Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Treatment

Table 02: Global Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 03: Global Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Region

Table 04: North America Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 05: North America Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Treatment

Table 06: North America Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 07: Latin America Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 08: Latin America Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Treatment

Table 09: Latin America Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 10: Europe Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 11: Europe Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Treatment

Table 12: Europe Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 13: East Asia Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 14: East Asia Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Treatment

Table 15: East Asia Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 16: South Asia Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 17: South Asia Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Treatment

Table 18: South Asia Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 19: Oceania Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 20: Oceania Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Treatment

Table 21: Oceania Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Table 22: Middle East and Africa (MEA) Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 23: Middle East and Africa (MEA) Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Treatment

Table 24: Middle East and Africa (MEA) Overweight Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Distribution Channel

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 01: Global Overweight Treatment Market Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 02: Global Overweight Treatment Market Value (US$ Mn), 2022 – 2032 & Y-o-Y Growth Trend Analysis

Figure 03: Global Overweight Treatment Market Absolute $ Opportunity, 2022-2032

Figure 04: Global Overweight Treatment Market Share Analysis (%), By Treatment, 2022-2032

Figure 05: Global Overweight Treatment Market Y-o-Y Analysis (%), By Treatment, 2022-2032

Figure 06: Global Overweight Treatment Market Attractiveness Analysis by Treatment, 2022 – 2032

Figure 07: Global Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022-2032

Figure 08: Global Overweight Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2022-2032

Figure 09: Global Overweight Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2032

Figure 10: Global Overweight Treatment Market Share Analysis (%), By Region, 2022-2032

Figure 11: Global Overweight Treatment Market Y-o-Y Analysis (%), By Region, 2022-2032

Figure 12: Global Overweight Treatment Market Attractiveness Analysis by Region, 2022-2032

Figure 13: North America Overweight Treatment Market Share Analysis (%), By Country (2022)

Figure 14: North America Overweight Treatment Market Share Analysis (%), By Treatment (2022)

Figure 15: North America Overweight Treatment Market Share Analysis (%), By Distribution Channel (2022)

Figure 16: North America Overweight Treatment Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 17: North America Overweight Treatment Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 18: North America Overweight Treatment   Market Attractiveness Analysis, By Country

Figure 19: North America Overweight Treatment Market Attractiveness Analysis, By Treatment

Figure 20: North America Overweight Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 21: U.S. Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 22: U.S. Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 23: Canada Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 24: Canada Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 25: Latin America Overweight Treatment Market Share Analysis (%), By Country (2022)

Figure 26: Latin America Overweight Treatment Market Share Analysis (%), By Treatment (2022)

Figure 27: Latin America Overweight Treatment Market Share Analysis (%), By Distribution Channel (2022)

Figure 28: Latin America Overweight Treatment Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 29: Latin America Overweight Treatment Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 30: Latin America Overweight Treatment   Market Attractiveness Analysis, By Country

Figure 31: Latin America Overweight Treatment Market Attractiveness Analysis, By Treatment

Figure 32: Latin America Overweight Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 33: Mexico Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 34: Mexico Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 35: Brazil Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 36: Brazil Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 37: Argentina Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 38: Argentina Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 39: Europe Overweight Treatment Market Share Analysis (%), By Country (2022)

Figure 40: Europe Overweight Treatment Market Share Analysis (%), By Treatment (2022)

Figure 41: Europe Overweight Treatment Market Share Analysis (%), By Distribution Channel (2022)

Figure 42: Europe Overweight Treatment Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 43: Europe Overweight Treatment Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 44: Europe Overweight Treatment   Market Attractiveness Analysis, By Country

Figure 45: Europe Overweight Treatment Market Attractiveness Analysis, By Treatment

Figure 46: Europe Overweight Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 47: Germany Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 48: Germany Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 49: Italy Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 50: Italy Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 51: France Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 52: France Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 53: U.K. Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 54: U.K. Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 55: Spain Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 56: Spain Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 57: BENELUX Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 58: BENELUX Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 59: Nordic Countries and Russia Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 60: Nordic Countries and Russia Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 61: East Asia Overweight Treatment Market Share Analysis (%), By Country (2022)

Figure 62: East Asia Overweight Treatment Market Share Analysis (%), By Treatment (2022)

Figure 63: East Asia Overweight Treatment Market Share Analysis (%), By Distribution Channel (2022)

Figure 64: East Asia Overweight Treatment Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 65: East Asia Overweight Treatment Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 66: East Asia Overweight Treatment   Market Attractiveness Analysis, By Country

Figure 67: East Asia Overweight Treatment Market Attractiveness Analysis, By Treatment

Figure 68: East Asia Overweight Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 69: China Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 70: China Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 71: Japan Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 72: Japan Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 73: South Korea Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 74: South Korea Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 75: South Asia Overweight Treatment Market Share Analysis (%), By Country (2022)

Figure 76: South Asia Overweight Treatment Market Share Analysis (%), By Treatment (2022)

Figure 77: South Asia Overweight Treatment Market Share Analysis (%), By Distribution Channel (2022)

Figure 78: South Asia Overweight Treatment Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 79: South Asia Overweight Treatment Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 80: South Asia Overweight Treatment   Market Attractiveness Analysis, By Country

Figure 81: South Asia Overweight Treatment Market Attractiveness Analysis, By Treatment

Figure 82: South Asia Overweight Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 83: India Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 84: India Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 85: Indonesia Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 86: Indonesia Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 88: Malaysia Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 88: Malaysia Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 89: Philippines Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 90: Philippines Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 91: Thailand Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 92: Thailand Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 93: Vietnam Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 94: Vietnam Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 95: Oceania Overweight Treatment Market Share Analysis (%), By Country (2022)

Figure 96: Oceania Overweight Treatment Market Share Analysis (%), By Treatment (2022)

Figure 97: Oceania Overweight Treatment Market Share Analysis (%), By Distribution Channel (2022)

Figure 98: Oceania Overweight Treatment Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 99: Oceania Overweight Treatment Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 100: Oceania Overweight Treatment   Market Attractiveness Analysis, By Country

Figure 101: Oceania Overweight Treatment Market Attractiveness Analysis, By Treatment

Figure 101: Oceania Overweight Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 102: Australia Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 103: Australia Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 104: New Zealand Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 105: New Zealand Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 106: Middle East and Africa (MEA) Overweight Treatment Market Share Analysis (%), By Country (2022)

Figure 107: Middle East and Africa (MEA) Overweight Treatment Market Share Analysis (%), By Treatment (2022)

Figure 108: Middle East and Africa (MEA) Overweight Treatment Market Share Analysis (%), By Distribution Channel (2022)

Figure 109: Middle East and Africa (MEA) Overweight Treatment Historical Market Value (US$ Mn) Analysis, 2017-2021

Figure 110: Middle East and Africa (MEA) Overweight Treatment Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 111: Middle East and Africa (MEA) Overweight Treatment   Market Attractiveness Analysis, By Country

Figure 112: Middle East and Africa (MEA) Overweight Treatment Market Attractiveness Analysis, By Treatment

Figure 113: Middle East and Africa (MEA) Overweight Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 114: GCC Countries Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 115: GCC Countries Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 116: Israel Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 117: Israel Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 118: Turkey Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 119: Turkey Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 120: South and North Africa Overweight Treatment Market Share Analysis (%), By Treatment, 2022 & 2032

Figure 121: South and North Africa Overweight Treatment Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Overweight Treatment Market: Scope of the Report

The latest publication by Persistence Market Research on the overweight treatment market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for overweight treatment products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the overweight treatment market. insights and information presented in this persistence market research study can be leveraged by shareholders in the overweight treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the overweight treatment market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the overweight treatment market offers information divided into three important segments – treatment, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Treatment

  • Drug Treatment
    • Bupropion and Naltrexone
    • Orlistat
    • Phentermine and Topiramate
    • Liraglutide
    • Others
  • Supplements
    • Medical Devices / Implants
    • Gastric Balloons
    • Gastric Bands
    • Stapling Devices

Distribution Channel

  • Institutional Sales
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Supermarkets/ Hypermarkets
    • Health & Beauty Stores
  • Online Sales

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for overweight treatment over the coming years?
  • How will changing trends impact the market?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the overweight treatment market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the overweight treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the overweight treatment market are more accurate and reliable.

Recommendations

Asia Pacific North America Europe Fluorinated Solvents Market

The Asia Pacific Fluorinated Solvents market is expected to register a CAGR of 9.0% over the forecast period (2018–2026)..

Isoparaffin Solvents Market

The incremental $ opportunity created by the market during the forecast period is pegged at nearly US$ 51.9 Mn. The isoparaffin solvents market is expected to expand at a CAGR of 3.7% during the forecast period..

Emea Dearomatic Solvents Market

Global De-aromatic solvents market is expected to register a CAGR of 5.0% over the forecast period (2016 – 2024), to reach valuation of US$ 556.0 Mn by 2024.

Bismuth Market

Global bismuth market is estimated reach around US$ 225 Mn in 2016 and is projected to expand at a moderate single-digit CAGR in terms of value from 2016-2024.

Our Clients

Our Clients